{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:59:20Z","timestamp":1781881160681,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"DOI":"10.7759\/cureus.111146","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:24:51Z","timestamp":1781879091000},"source":"Crossref","is-referenced-by-count":0,"title":["Differential Proteomic Response to Smoking Exposure Underlies Reduced Parkinson\u2019s Disease Risk in Women"],"prefix":"10.7759","author":[{"given":"Steven","family":"Lehrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rheinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29707","article-title":"Clearing the smoke: what protects smokers from Parkinson's disease?","volume":"39","author":"Rose KN","year":"2024","unstructured":"Rose KN, Schwarzschild MA, Gomperts SN. Clearing the smoke: what protects smokers from Parkinson's disease?. Mov Disord. 2024, 39:267-72. 10.1002\/mds.29707","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21689","article-title":"Constipation and cigarette smoking are independent influences for Parkinson's disease","volume":"14","author":"Lehrer S","year":"2022","unstructured":"Lehrer S, Rheinstein PH. Constipation and cigarette smoking are independent influences for Parkinson's disease. Cureus. 2022, 14:e21689. 10.7759\/cureus.21689","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations","volume":"622","author":"Eldjarn GH","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, et al.. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023, 622:348-58. 10.1038\/s41586-023-06563-x","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft C","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al.. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018, 562:203-9. 10.1038\/s41586-018-0579-z","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","article-title":"Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis","volume":"20","author":"Wik L","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, et al.. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021, 20:100168. 10.1016\/j.mcpro.2021.100168","journal-title":"Mol Cell Proteomics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1368-25.2026","article-title":"Genetically encoded constitutive upregulation of \u03b22 subunit containing neuronal nicotinic acetylcholine receptors is neuroprotective in female parkinsonian mice","volume":"46","author":"Pandey G","year":"2026","unstructured":"Pandey G, Garcia RC, Das D, et al.. Genetically encoded constitutive upregulation of \u03b22 subunit containing neuronal nicotinic acetylcholine receptors is neuroprotective in female parkinsonian mice. J Neurosci. 2026, 46:10.1523\/JNEUROSCI.1368-25.2026","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson's disease: implications for therapy","volume":"23","author":"Quik M","year":"2008","unstructured":"Quik M, O'Leary K, Tanner CM. Nicotine and Parkinson's disease: implications for therapy. Mov Disord. 2008, 23:1641-52. 10.1002\/mds.21900","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200311","article-title":"Transdermal nicotine treatment and progression of early Parkinson's disease","volume":"2","author":"Oertel WH","year":"2023","unstructured":"Oertel WH, M\u00fcller HH, Unger MM, et al.. Transdermal nicotine treatment and progression of early Parkinson's disease. NEJM Evid. 2023, 2:EVIDoa2200311. 10.1056\/EVIDoa2200311","journal-title":"NEJM Evid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081814","article-title":"Nicotine therapy for Parkinson's disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Liang CH","year":"2025","unstructured":"Liang CH, Huang TW, Chiu WT, Chung CC, Hong CT. Nicotine therapy for Parkinson's disease: a meta-analysis of randomized controlled trials. Biomedicines. 2025, 13:10.3390\/biomedicines13081814","journal-title":"Biomedicines"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2024.06.007","article-title":"The enigma of the 'smoker's paradox': results from a single-center registry of patients with STEMI undergoing primary percutaneous coronary intervention","volume":"69","author":"Paradossi U","year":"2024","unstructured":"Paradossi U, De Caterina AR, Trimarchi G, et al.. The enigma of the 'smoker's paradox': results from a single-center registry of patients with STEMI undergoing primary percutaneous coronary intervention. Cardiovasc Revasc Med. 2024, 69:42-9. 10.1016\/j.carrev.2024.06.007","journal-title":"Cardiovasc Revasc Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29952","article-title":"The role of BAG3 in health and disease: a \"magic bag of tricks\"","volume":"123","author":"Lin H","year":"2022","unstructured":"Lin H, Koren SA, Cvetojevic G, Girardi P, Johnson GV. The role of BAG3 in health and disease: a \"magic bag of tricks\". J Cell Biochem. 2022, 123:4-21. 10.1002\/jcb.29952","journal-title":"J Cell Biochem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027373","article-title":"Genetics of BAG3: a paradigm for developing precision therapies for dilated cardiomyopathies","volume":"11","author":"Qu HQ","year":"2022","unstructured":"Qu HQ, Feldman AM, Hakonarson H. Genetics of BAG3: a paradigm for developing precision therapies for dilated cardiomyopathies. J Am Heart Assoc. 2022, 11:e027373. 10.1161\/JAHA.122.027373","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499175-differential-proteomic-response-to-smoking-exposure-underlies-reduced-parkinsons-disease-risk-in-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:24:52Z","timestamp":1781879092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499175-differential-proteomic-response-to-smoking-exposure-underlies-reduced-parkinsons-disease-risk-in-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.111146","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}